Sanofi

Latest stories

6h
The Economic Times
Pharma sector set for wave of mergers, acquisitions: EYin Medivation, a California-based biotechnology firm specialising in cancer tre
Pharma sector set for wave of mergers, acquisitions: EY
The Economic Times / Posted 6 hours ago
in Medivation, a California-based biotechnology firm specialising in cancer treatments that is also coveted by French group Sanofi and US firm Amgen. Also in the US, Abbott Laboratories and St. Jude Medical, leading makers of heart care and... Read more
1d
dna
Govt to study impact of FDI in pharma amid takeover woesbillion. Another US company Mylan bought Matrix Lab while Dabur Pharma was acqu
Govt to study impact of FDI in pharma amid takeover woes
dna / Posted yesterday
billion. Another US company Mylan bought Matrix Lab while Dabur Pharma was acquired by Singapore's Fresenius and France's Sanofi Aventis purchased Shanta Biotech and certain assets of Orchid Chemicals were acquired by US-based Hospira. As per... Read more
1d
Naked Capitalism
Are You Ready for Some (Political) Football? The NFL, Concussion Research, the NIH, and the Revolving DoorAlso according to her official BWH biography, Dr Nabel’s husband is one Gary Na
Are You Ready for Some (Political) Football? The NFL, Concussion Research, the NIH, and the Revolving Door
Naked Capitalism / Posted yesterday
Also according to her official BWH biography, Dr Nabel’s husband is one Gary Nabel, now the chief scientific officer at Sanofi. Dr Gary Nabel, in turn, was Director of the Vaccine Research Center at the National Institute for Allergy and... Read more
2d
Times News
Weatherly graduation speaker announceddesign, and project management. Currently, he is deputy director, pharmaceutic
Weatherly graduation speaker announced
Times News / Posted 2 days ago
design, and project management. Currently, he is deputy director, pharmaceutical technology, at the vaccine manufacturer Sanofi Pasteur in Swiftwater. His focus is on development of manufacturing processes for new vaccines and site-to-site... Read more
2d
The Borneo Post
‘Hand-clapping exercise not MoE directive’present were deputy director general of Health (Public Health), Datuk Dr Lokman
‘Hand-clapping exercise not MoE directive’
The Borneo Post / Posted 2 days ago
present were deputy director general of Health (Public Health), Datuk Dr Lokman Hakim Sulaiman, and managing director of Sanofi Pasteur Malaysia, Singapore and Brunei, Baptiste de Clarens. Kamalanathan was commenting on a video footage spread on... Read more
3d
FOX Business
3 Biotech Stocks to Buy in Junehave exactly that in its diabetes drug, sotagliflozin. What makes the drug so e
3 Biotech Stocks to Buy in June
FOX Business / Posted 3 days ago
have exactly that in its diabetes drug, sotagliflozin. What makes the drug so exciting, and likely the reason Big Pharma Sanofijumped aboard with a partnering deal worth an eye-popping $1.7 billion in milestones last November, is sotagliflozin's... Read more
3d
FOX Business
3 Biotech Stocks to Buy in Junehave exactly that in its diabetes drug, sotagliflozin. What makes the drug so e
3 Biotech Stocks to Buy in June
FOX Business / Posted 3 days ago
have exactly that in its diabetes drug, sotagliflozin. What makes the drug so exciting, and likely the reason Big Pharma Sanofijumped aboard with a partnering deal worth an eye-popping $1.7 billion in milestones last November, is sotagliflozin's... Read more
3d
Bureau County Republican
Josephine BarberHolubek, she married Frank Barber Dec. 15, 1946, in Chicago. He preceded her in
Josephine Barber
Bureau County Republican / Posted 3 days ago
Holubek, she married Frank Barber Dec. 15, 1946, in Chicago. He preceded her in death on May 25, 1986. She was employed at Sanofi Drug in Des Plaines for many years until her retirement. Survivors include one daughter, Judy (Greg) Foster of... Read more
3d
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochesource: Regeneron Pharmaceuticals, Inc. Regeneron also reported $399.3 million
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted 3 days ago
source: Regeneron Pharmaceuticals, Inc. Regeneron also reported $399.3 million in collaboration revenue from partnersSanofiandBayer. Bayer's contribution of $179.6 million was mostly in connection with outside-the-U.S. commercialization of... Read more
3d
FOX Business
Regeneron Pharmaceuticals, Inc. vs. Rochesource: Regeneron Pharmaceuticals, Inc. Regeneron also reported $399.3 million
Regeneron Pharmaceuticals, Inc. vs. Roche
FOX Business / Posted 3 days ago
source: Regeneron Pharmaceuticals, Inc. Regeneron also reported $399.3 million in collaboration revenue from partnersSanofiandBayer. Bayer's contribution of $179.6 million was mostly in connection with outside-the-U.S. commercialization of... Read more
3d
FOX News
New HIV vaccine trial aims to build on earlier modest successdummy shots. The half receiving the active injection will actually be getting t
New HIV vaccine trial aims to build on earlier modest success
FOX News / Posted 3 days ago
dummy shots. The half receiving the active injection will actually be getting two vaccines. One known as ALVAC-HIV is from Sanofi Pasteur, and the second is a bivalent gp120 protein subunit vaccine from GlaxoSmithKline. "You're basically getting a... Read more
3d
Business Wire
Medivation Files Preliminary Consent Revocation Statementthat it has filed a preliminary Consent Revocation Statement with the Securitie
Medivation Files Preliminary Consent Revocation Statement
Business Wire / Posted 3 days ago
that it has filed a preliminary Consent Revocation Statement with the Securities and Exchange Commission in response to Sanofi’s preliminary consent solicitation statement filed on May 25, 2016. Both sets of materials are subject to the SEC... Read more
3d
Japan Today
Call for gastric surgery to be standard diabetes treatment ‹ Japan Todaycases this would lead to patients being able to give up or significantly reduce
Call for gastric surgery to be standard diabetes treatment ‹ Japan Today
Japan Today / Posted 3 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world’s leading suppliers of insulin and other diabetes drugs. Nick Finer, a University College... Read more
134 related stories
3d
Fortune
Cancer Drugs Are The Least Likely to Receive FDA Approvalpersonalized therapies. “I think that trend started, for me, in 2012,” said BIO
Cancer Drugs Are The Least Likely to Receive FDA Approval
Fortune / Posted 3 days ago
personalized therapies. “I think that trend started, for me, in 2012,” said BIO’s Thomas. “That’s when [French drugmaker] Sanofi bought [the biotech firm] Genzyme. And what’s influencing the rate of success for both [rare diseases and biomarkers... Read more
4d
MedCity News
MIT invents machine for fast pharma prototype-makingabout the widespread use of this device, says Dr. Paul Beninger, who oversees p
MIT invents machine for fast pharma prototype-making
MedCity News / Posted 4 days ago
about the widespread use of this device, says Dr. Paul Beninger, who oversees pharmaceutical safety at manufacturer Genzyme Sanofi. He said first and foremost, the drug industry worries about intellectual property rights. Drug manufacturers own... Read more
4d
The Mendota Reporter
Mendota Reporter Josephine BarberAdele Svacina. She was preceded in death by her husband; one brother, Louis; a
Mendota Reporter Josephine Barber
The Mendota Reporter / Posted 4 days ago
Adele Svacina. She was preceded in death by her husband; one brother, Louis; and two sisters. Josephine was employed at Sanofi Drug in Des Plaines for many years until her retirement. She enjoyed cooking, baking and quilting. Leave condolences... Read more
4d
FOX Business
5 Things You Need to Know About Zika Virusterm. Here's what you need to know about Zika virus, and the efforts underway a
5 Things You Need to Know About Zika Virus
FOX Business / Posted 4 days ago
term. Here's what you need to know about Zika virus, and the efforts underway at Intrexon , Inovio Pharmaceuticals , and Sanofi . This isn't the next Ebola The disease poses a very serious public-health threat (more on that below), but this... Read more
4d
FOX Business
5 Things You Need to Know About Zika Virusterm. Here's what you need to know about Zika virus, and the efforts underway a
5 Things You Need to Know About Zika Virus
FOX Business / Posted 4 days ago
term. Here's what you need to know about Zika virus, and the efforts underway at Intrexon , Inovio Pharmaceuticals , and Sanofi . This isn't the next Ebola The disease poses a very serious public-health threat (more on that below), but this... Read more
4d
The Hendersonville Times-News
Asian stocks mixed amid concerns oil rally unsustainableand gave weak projections for the rest of the year, and its stock fell $1.35, o
Asian stocks mixed amid concerns oil rally unsustainable
The Hendersonville Times-News / Posted 4 days ago
and gave weak projections for the rest of the year, and its stock fell $1.35, or 8.4 percent, to $14.68. French drugmaker Sanofi said it wants to replace the entire board of cancer drug Medivation. Sanofi has offered to buy the company for $9.3... Read more
18 related stories
4d
Your Hometown Lima Stations
Energy companies lead the way as US stocks keep risingand gave weak projections for the rest of the year, and its stock fell $1.35, o
Energy companies lead the way as US stocks keep rising
Your Hometown Lima Stations / Posted 4 days ago
and gave weak projections for the rest of the year, and its stock fell $1.35, or 8.4 percent, to $14.68. French drugmaker Sanofi said it wants to replace the entire board of cancer drug Medivation. Sanofi has offered to buy the company for $9.3... Read more
18 related stories
4d
WFTV 9 Orlando
Energy companies lead the way as US stocks keep risingand gave weak projections for the rest of the year, and its stock fell $1.35, o
Energy companies lead the way as US stocks keep rising
WFTV 9 Orlando / Posted 4 days ago
and gave weak projections for the rest of the year, and its stock fell $1.35, or 8.4 percent, to $14.68. French drugmaker Sanofi said it wants to replace the entire board of cancer drug Medivation. Sanofi has offered to buy the company for $9.3... Read more
18 related stories
4d
Island Packet
Energy companies lead the way as US stocks keep risingand gave weak projections for the rest of the year, and its stock fell $1.35, o
Energy companies lead the way as US stocks keep rising
Island Packet / Posted 4 days ago
and gave weak projections for the rest of the year, and its stock fell $1.35, or 8.4 percent, to $14.68. French drugmaker Sanofi said it wants to replace the entire board of cancer drug Medivation. Sanofi has offered to buy the company for $9.3... Read more
18 related stories
4d
The Middletown Press
Energy companies lead the way as US stocks keep risingand gave weak projections for the rest of the year, and its stock fell $1.35, o
Energy companies lead the way as US stocks keep rising
The Middletown Press / Posted 4 days ago
and gave weak projections for the rest of the year, and its stock fell $1.35, or 8.4 percent, to $14.68. French drugmaker Sanofi said it wants to replace the entire board of cancer drug Medivation. Sanofi has offered to buy the company for $9.3... Read more
18 related stories
4d
Channel NewsAsia
US panel backs approval of Sanofi combination diabetes drugdrug made by Novo Nordisk A/S, a U.S. advisory panel on Wednesday recommended a
US panel backs approval of Sanofi combination diabetes drug
Channel NewsAsia / Posted 4 days ago
drug made by Novo Nordisk A/S, a U.S. advisory panel on Wednesday recommended approval of a similar product made by Sanofi SA. The panel voted 12-2, with one person not voting, that the Food and Drug Administration should approve Sanofi's... Read more
3 related stories
5d
dna
Call for gastric surgery to be made standard treatment for diabetescases this would lead to patients being able to give up or significantly reduce
Call for gastric surgery to be made standard treatment for diabetes
dna / Posted 5 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world's leading suppliers of insulin and other diabetes drugs. "Surgery represents a radical... Read more
134 related stories
5d
Los Angeles Times
Stocks climb for the second day as energy companies jumpTiffany said it expects its profit to decline this year, and its stock slid $1.
Stocks climb for the second day as energy companies jump
Los Angeles Times / Posted 5 days ago
Tiffany said it expects its profit to decline this year, and its stock slid $1.27, or 2%, to $62.58. French drugmaker Sanofi said it wants to replace the entire board of Medivation. The cancer drug maker rejected a $9.3-billion offer from... Read more
18 related stories
5d
Salon.com
Sanofi wants to dump Medivation’s board after rejected dealNEW YORK (AP) — French drug company Sanofi is trying to toss the entire board a
Sanofi wants to dump Medivation’s board after rejected deal
Salon.com / Posted 5 days ago
NEW YORK (AP) — French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid. Sanofi said Medivation has refused to discuss a deal. It named eight people on Wednesday... Read more
6 related stories
5d
MyMotherLode.com
Sanofi wants to dump Medivation's board after rejected deal AP News | 05/25/16 06:50 AM NEW YORK (AP) -- French drug company Sanofi is t
Sanofi wants to dump Medivation's board after rejected deal
MyMotherLode.com / Posted 5 days ago
AP News | 05/25/16 06:50 AM NEW YORK (AP) -- French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover... Read more
6 related stories
5d
The Record Searchlight
Sanofi wants to dump Medivation's board after rejected dealNEW YORK (AP) - French drug company Sanofi is trying to toss the entire board a
Sanofi wants to dump Medivation's board after rejected deal
The Record Searchlight / Posted 5 days ago
NEW YORK (AP) - French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid. Sanofi says Medivation has refused to discuss a deal. On Wednesday it named eight people... Read more
6 related stories
5d
Market Watch
Sanofi moves on vote to replace Medivation boardPARIS--French drugmaker Sanofi SA said Wednesday it is moving to call a vote on
Sanofi moves on vote to replace Medivation board
Market Watch / Posted 5 days ago
PARIS--French drugmaker Sanofi SA said Wednesday it is moving to call a vote on whether to remove the entire board of Medivation Inc. after the U.S. biotech company refused to engage in takeover talks. Sanofi said it had filed the necessary... Read more
6 related stories
5d
MedCity News
Novo Nordisk passes milestone as FDA panel greenlights new diabetes drugalert an individual’s immune system to call off an attack — antigen-specific to
Novo Nordisk passes milestone as FDA panel greenlights new diabetes drug
MedCity News / Posted 5 days ago
alert an individual’s immune system to call off an attack — antigen-specific tolerance. The biotech is collaborating with Sanofi to develop treatments for celiac disease and Type 1 diabetes. — Xconomy Entellus Medical, a medical device maker, has... Read more
5d
Morningstar
3 High-Quality Stocks to Buy Nowfull screen here. Three of the most undervalued wide-moat stocks appear below.
3 High-Quality Stocks to Buy Now
Morningstar / Posted 5 days ago
full screen here. Three of the most undervalued wide-moat stocks appear below. Fair value uncertainty: Medium Drugmaker Sanofi earns a wide moat based on the stable cash flows generated by its diverse portfolio of vaccines, drugs, and consumer... Read more
5d
Channel NewsAsia
French drugmaker Sanofi to step up push into ChinaPARIS: Sanofi will step up its push into China, its second biggest market after
French drugmaker Sanofi to step up push into China
Channel NewsAsia / Posted 5 days ago
PARIS: Sanofi will step up its push into China, its second biggest market after the United States, in the next five years as part of a wider expansion into emerging countries, where it sees a large part of its future growth. The French drugmaker is... Read more
5d
The Star
Top foreign and local stories at 4pmTop foregn stories Sanofi to unveil challenge to Medivation’s board: France’s S
Top foreign and local stories at 4pm
The Star / Posted 5 days ago
Top foregn stories Sanofi to unveil challenge to Medivation’s board: France’s Sanofi SA is preparing to name candidates it will put forward to replace the entire board of US cancer drug company Medivation Inc as early as Wednesday, according to... Read more
5d
The Star
Sanofi to unveil challenge to Medivation's boardNew York: France's Sanofi SA is preparing to name candidates it will put forwar
Sanofi to unveil challenge to Medivation's board
The Star / Posted 5 days ago
New York: France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of US cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter. Sanofi has threatened to oust... Read more
6 related stories
5d
Decclan Chronicle
Call for gastric surgery to be standard diabetes treatmentcases this would lead to patients being able to give up or significantly reduce
Call for gastric surgery to be standard diabetes treatment
Decclan Chronicle / Posted 5 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world's leading suppliers of insulin and other diabetes drugs. Nick Finer, a University College... Read more
134 related stories
5d
Reuters
Sanofi to unveil challenge to Medivation's boardFrench multinational pharmaceutical company SANOFI logo is seen at the headquar
Sanofi to unveil challenge to Medivation's board
Reuters / Posted 5 days ago
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. France's Sanofi SA (SASY.PA) is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug... Read more
6 related stories
5d
Business Wire
Sanofi Genzyme Launches its vs.MS Global Campaign to Address the Physical and Emotional Burden of Multiple SclerosisThis World MS Day, Sanofi Genzyme is putting a call out to the MS community to
Sanofi Genzyme Launches its vs.MS Global Campaign to Address the Physical and Emotional Burden of Multiple Sclerosis
Business Wire / Posted 5 days ago
This World MS Day, Sanofi Genzyme is putting a call out to the MS community to learn more about the real impact of the disease and to declare themselves vs.MS on the campaign website, www.vs-MS.com. For each vs.MS declaration, Sanofi Genzyme will... Read more
5d
Channel NewsAsia
Sanofi to unveil challenge to Medivation's boardREUTERS: France's Sanofi SA is preparing to name candidates it will put forward
Sanofi to unveil challenge to Medivation's board
Channel NewsAsia / Posted 5 days ago
REUTERS: France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter. Sanofi has threatened to oust... Read more
6 related stories
5d
FOX Business
Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.discovery deal between Ionis (then called Isis) and Biogen. Alnylam, on the ot
Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.
FOX Business / Posted 5 days ago
discovery deal between Ionis (then called Isis) and Biogen. Alnylam, on the other hand, has multi-drug deals withSanofi that date back to 2012, when it licensed Alnylam's transthyretin-mediated amyloidosis program. In 2014, Sanofi took a... Read more
5d
FOX Business
Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.discovery deal between Ionis (then called Isis) and Biogen. Alnylam, on the ot
Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.
FOX Business / Posted 5 days ago
discovery deal between Ionis (then called Isis) and Biogen. Alnylam, on the other hand, has multi-drug deals withSanofi that date back to 2012, when it licensed Alnylam's transthyretin-mediated amyloidosis program. In 2014, Sanofi took a... Read more
6d
Channel NewsAsia
Call for gastric surgery to be standard diabetes treatmentcases this would lead to patients being able to give up or significantly reduce
Call for gastric surgery to be standard diabetes treatment
Channel NewsAsia / Posted 6 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world's leading suppliers of insulin and other diabetes drugs. Nick Finer, a University College... Read more
134 related stories
6d
Boston Globe
Mass Innovation Labs targets smaller startupsthe newest entrant, is looking to expand aggressively. Its Kendall Square build
Mass Innovation Labs targets smaller startups
Boston Globe / Posted 6 days ago
the newest entrant, is looking to expand aggressively. Its Kendall Square building also leases space to biopharma companies Sanofi Genzyme and Momenta Pharmaceuticals Inc., so Mass Innovation Labs has signed a letter of intent for an additional... Read more
6d
FOX News
Specialists call for gastric surgery to be standard diabetes treatmentcases this would lead to patients being able to give up or significantly reduce
Specialists call for gastric surgery to be standard diabetes treatment
FOX News / Posted 6 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world's leading suppliers of insulin and other diabetes drugs. "Surgery represents a radical... Read more
134 related stories
6d
Channel NewsAsia
Specialists call for gastric surgery to be standard diabetes treatmentcases this would lead to patients being able to give up or significantly reduce
Specialists call for gastric surgery to be standard diabetes treatment
Channel NewsAsia / Posted 6 days ago
cases this would lead to patients being able to give up or significantly reduce their diabetes medications. Novo Nordisk, Sanofi and Eli Lilly are the world's leading suppliers of insulin and other diabetes drugs. "Surgery represents a radical... Read more
6d
Philly.com
Local researchers race to develop Zika vaccineexpert David Weiner, now at Wistar. Inovio expects to begin clinical tests in p
Local researchers race to develop Zika vaccine
Philly.com / Posted 6 days ago
expert David Weiner, now at Wistar. Inovio expects to begin clinical tests in people in the next few months. French-based Sanofi Pasteur, with U.S. headquarters in Swiftwater, in the Poconos, also is developing a Zika vaccine. Sanofi currently... Read more
6d
Business Wire
US and Europe Insulin Market 2016- Advances in Insulin Delivery Technology Drives the Marketthat could have an adverse impact on market growth is the complexity of the ins
US and Europe Insulin Market 2016- Advances in Insulin Delivery Technology Drives the Market
Business Wire / Posted 6 days ago
that could have an adverse impact on market growth is the complexity of the insulin production process. Key vendors - Sanofi - Novo Nordisk - Eli Lilly Other prominent vendors - Adocia - Biocon - Biodel - Biogenomics - Boehringer... Read more
6d
Business Wire
Evotec Extends Integrated Drug Discovery Alliance with GenentechUCB and development partnerships with e.g. Janssen Pharmaceuticals in the field
Evotec Extends Integrated Drug Discovery Alliance with Genentech
Business Wire / Posted 6 days ago
UCB and development partnerships with e.g. Janssen Pharmaceuticals in the field of Alzheimer's disease, with MedImmune and Sanofi in the field of diabetes, with Pfizer in the field of tissue fibrosis and with Second Genome in the field of... Read more
6d
Business Wire
Evotec verlängert integrierte Wirkstoffforschungsallianz mit GenentechEntwicklungspartnerschaften u. a. mit Janssen Pharmaceuticals im Bereich der Al
Evotec verlängert integrierte Wirkstoffforschungsallianz mit Genentech
Business Wire / Posted 6 days ago
Entwicklungspartnerschaften u. a. mit Janssen Pharmaceuticals im Bereich der Alzheimer'schen Erkrankung, mit MedImmune und Sanofi im Bereich Diabetes, mit Pfizer auf dem Gebiet Organfibrose und mit Second Genome im Bereich Entzündungskrankheiten.... Read more
637 related stories
6d
Fortune
Sanofi Is Shuffling Its Exec Roster Amid Continued Strugglesand vaccines units, is making several notable changes to its executive committe
Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles
Fortune / Posted 6 days ago
and vaccines units, is making several notable changes to its executive committee, including the addition of current Sanofi Pasteur (the company’s vaccines arm) senior vice president of global commercial operations David Loew and the planned... Read more
More

People in this news